Bristol-Myers Squibb Co. (BMY) PT Raised to $66 at Truist Securities

February 5, 2021 8:43 AM

Truist Securities raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $66.00 (from $65.00) while maintaining a Hold rating.

No results found